Skip to main content
. 2019 Jun 4;39(6):BSR20190288. doi: 10.1042/BSR20190288

Table 5. The median survival of TNBC patients with different metastasis (n=1330).

Metastatic site Patients, number Median BCSS Median OS
95% CI, months 95% CI, months
Overall 1330 13 (12.2–13.8) 13 (12.2–13.8)
Bone only 258 14 (12.4–15.6) 13 (11.5–14.5)
Brain only 38 5 (2.6–7.4) 5 (2.6–7.4)
Liver only 122 15 (12.8–17.2) 14 (12.2–15.8)
Lung only 261 15 (12.2–17.8) 15 (12.5–17.5)
Bone+other 291 8 (6.3–9.7) 8 (6.3–9.7)